Minimally invasive islet transplantation for patients with type 1 diabetes achieves insulin independence and reverses the progression of atherosclerosis in the first few years after transplant, according to a University of Illinois at Chicago study.
In the video below, you’ll see Tom’s portable smartphone artificial pancreas system in action and learn more about how JDRF has managed to efficiently accelerate this groundbreaking technology in just a few years.
Now a University of Chicago study shows that transplanting pancreatic islets to type 1s significantly reduces carotid artery thickness, lowering both A1c levels and the attendant risk of atherosclerosis.
Type 1 and type 2 diabetes results when beta cells in the pancreas fail to produce enough insulin, the hormone that regulates blood sugar. One approach to treating diabetes is to stimulate regeneration of new beta cells.
In most areas of diabetes research, you don’t hear much until there’s a big breakthrough of some sort. And then it goes dark again. That’s what happened several years ago on the then-hot topic of xenotransplantation, or the sourcing of islet cells for transplants.
A Sydney-based diabetes expert and a Queensland artificial intelligence specialist have tested the prototype of a software program that could replicate the role of a human pancreas.
An implantable sensor that allows diabetics to more effectively monitor their blood-sugar levels is a step closer to reality, thanks to a researcher at Texas A&M University who is developing technology aimed at enabling these sensors to remain functional in the body for an extended period of time.
A diabetes specialist and Artificial Intelligence expert have collaborated to test the prototype of an artificial pancreas. Should a planned clinical study and clinical trial support the excellent ‘simulated’ results obtained so far.
Kathleen is intimately familiar with the power of diabetes technology, having participated in a clinical trial for the Artificial Pancreas Project.
Wil Dubois answers some science-y questions about pancreas transplants and whether an immune-suppressant drug for HIV/AIDS and hepatitis could impact someone’s type 1 diabetes honeymoon.
The main objectives of pancreas transplant are to eliminate the patient’s dependency on insulin, to improve the quality of life and to reduce long-term diabetic complications.
The models simulate injections of insulin in the manner of insulin pumps, which deliver periodic impulses in diabetes patients.
For years, researchers have investigated how the body loses the ability to produce enough insulin, a hallmark of diabetes. Now an intriguing theory is emerging, and it suggests a potential treatment.
The Sansum Diabetes Research Institute is pleased to announce that researchers from Sansum and UCSB were among three awardees out of 128 entrants in the second annual Wyss Institute IEEE EMBS Award for Translational Research.
An artificial pancreas could eventually help diabetics to get their life back. It would work as the real one that no longer works. Many people are eager and excited for this.
The team has identified a cell surface marker on a subpopulation of cells in the pancreas that appears to identify them as pancreatic stem cells (PnSCs), a cell type which has never actually been demonstrated in human or animal tissues.
An ‘all-natural’ method for studying pancreatic islets, the small tissues responsible for insulin production and regulation in the body, has recently been developed by researchers at the University of Toronto.
The technology, which would combine an automated blood glucose monitor and insulin delivery system, could help prevent diabetic patients from experiencing complications associated with their disease, the researchers wrote.
The Japanese Pancreas and Islet Transplantation Association (JPITA) is preparing for the nation’s first transplantation of pancreatic islets from a brain-dead donor to a patient with Type 1 diabetes, it was learned Saturday.
The device is intended to automate much of the work of monitoring and maintaining safe blood sugar levels now performed by patients.